Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Developing and optimizing a computable phenotype for incident venous thromboembolism in a longitudinal cohort of patients with cancer.
Li A, da Costa WL Jr, Guffey D, Milner EM, Allam AK, Kurian KM, Novoa FJ, Poche MD, Bandyo R, Granada C, Wallace CD, Zakai NA, Amos CI. Li A, et al. Among authors: kurian km. Res Pract Thromb Haemost. 2022 May 25;6(4):e12733. doi: 10.1002/rth2.12733. eCollection 2022 May. Res Pract Thromb Haemost. 2022. PMID: 35647478 Free PMC article.
Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems.
Li A, La J, May SB, Guffey D, da Costa WL Jr, Amos CI, Bandyo R, Milner EM, Kurian KM, Chen DCR, Do NV, Granada C, Riaz N, Brophy MT, Chitalia V, Gaziano JM, Garcia DA, Carrier M, Flowers CR, Zakai NA, Fillmore NR. Li A, et al. Among authors: kurian km. J Clin Oncol. 2023 Jun 1;41(16):2926-2938. doi: 10.1200/JCO.22.01542. Epub 2023 Jan 10. J Clin Oncol. 2023. PMID: 36626707 Free PMC article.
Correction: Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.
Dave F, Herrera K, Lockley A, van de Weijer LL, Henderson S, Sofela AA, Hook L, Adams CL, Ercolano E, Hilton DA, Maze EA, Kurian KM, Ammoun S, Hanemann CO. Dave F, et al. Among authors: kurian km. Oncogene. 2024 Oct;43(41):3080. doi: 10.1038/s41388-024-03177-z. Oncogene. 2024. PMID: 39327460 Free PMC article. No abstract available.
Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.
Dave F, Herrera K, Lockley A, van de Weijer LL, Henderson S, Sofela AA, Hook L, Adams CL, Ercolano E, Hilton DA, Maze EA, Kurian KM, Ammoun S, Hanemann CO. Dave F, et al. Among authors: kurian km. Oncogene. 2024 Oct;43(41):3049-3061. doi: 10.1038/s41388-024-03131-z. Epub 2024 Aug 23. Oncogene. 2024. PMID: 39179860 Free PMC article.
Adult brain tumour research in 2024: Status, challenges and recommendations.
Purshouse K, Bulbeck HJ, Rooney AG, Noble KE, Carruthers RD, Thompson G, Hamerlik P, Yap C, Kurian KM, Jefferies SJ, Lopez JS, Jenkinson MD, Hanemann CO, Stead LF. Purshouse K, et al. Among authors: kurian km. Neuropathol Appl Neurobiol. 2024 Apr;50(2):e12979. doi: 10.1111/nan.12979. Neuropathol Appl Neurobiol. 2024. PMID: 38605644 Review.
103 results